Psychedelics and Ibogaine “Pain Medications” at the Pharmacy Counter: Implications for Pharmacy Practice

Frank Breve, Frank J Berenato, Joseph V. Pergolizzi, Giustino Varrassi, Robert B. Raffa

Journal of Pain Research July 1, 2026 Peer reviewed DOI: 10.2147/jpr.s629049 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Pharmacy practice Alternative medicine Community practice Medline Pharmaconomist

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial Palliative & Supportive Care • January 1, 2026 • via OpenAlex
Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review BJPsych Open • November 1, 2025 • via OpenAlex
Essentials of Informed Consent to Psychedelic Medicine JAMA Psychiatry • April 10, 2024 • via OpenAlex
A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations Therapeutic Advances in Psychopharmacology • March 1, 2026 • via OpenAlex

Comments

No comments yet.

Log in to comment